Drug intelligence / Profile preview

type iii collagen

Development stage
Preclinical
Lead developer
HTL Biotechnology
Modality
Recombinant Proteins and Enzymes
Administration
Topical (wound Dressings/biomaterials), Parenteral/injectable (experimental/regenerative Medicine), Oral (as Dietary Supplement; Not Absorbed Intact)[1][2]
01

Overview

Type III collagen is a fibrillar structural protein found abundantly in the extracellular matrix of connective tissues, especially in skin, lungs, intestinal walls, and blood vessels. It is initially synthesized as procollagen with three pro-alpha1(III) chains that form a triple helix structure. After post-translational modifications and enzymatic processing outside the cell, mature type III collagen assembles into stable fibrils that provide strength and elasticity to tissues. Type III collagen plays a crucial role in tissue repair and regeneration by facilitating proper fibrillogenesis of type I collagen and supporting cell proliferation and migration. Recombinant forms are produced for research or medical use via expression systems such as yeast or mammalian cells[6][7][8][9][10]. In clinical settings, it may be used as a biomaterial for wound healing or tissue engineering; commercially available products are often derived from human placenta or recombinant sources.

Other names
collagen type IIItype 3 collagentype3 collagentype-3 collagenCOL3A1COL-3A1COL 3A1
02

Targets

COL1 (Collagen type I)

Beyond the preview

Go deeper on type iii collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on type iii collagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call